• Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.
Ahmad, Gul, et al. J. Infect. Dis. 2011 Nov;204: 1437-49
• Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination.
Coe, Christopher L, et al. Age (Dordr) 2012 Oct;34: 1169-77
• Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.
De Swart, Rik L, et al. J. Virol. 2002 Nov;76: 11561-9
• Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge.
de Waal, Leon, et al. Vaccine 2004 Feb 25;22: 915-22
• Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys.
Haanstra, K G, et al. Clin. Exp. Immunol. 2009 Oct;158: 91-8
• Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
Polakos, N K, et al. J. Immunol. 2001 Mar 01;166: 3589-98
• Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta.
Qiu, Y, et al. Scand. J. Immunol. 2010 Nov;72: 425-33
• Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection.
Rout, Namita, et al. PLoS Pathog. 2012 Sep;8: e1002928
• Constitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1.
Yee, JoAnn L, et al. Comp. Med. 2013;63: 508-14
• Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.
Zhang, Weidong, et al. J. Investig. Med. 2018 Dec;8: 1124-1132